Term
HBsAG (-)
Anti-HBc (-)
Anti-HB2 (-)
|
|
Definition
|
|
Term
HBsAG (-)
Anti-HBc (+)
Anti-HB2 (+)
|
|
Definition
| Immune because of natural infection |
|
|
Term
HBsAG (-)
Anti-HBc (-)
Anti-HB2 (+)
|
|
Definition
| Immune due to the Hepatitis B vaccine |
|
|
Term
HBsAG (+)
Anti-HBC (+)
IGM Anti-HBC (+) |
|
Definition
|
|
Term
HBsAG (+)
Anti-HBC (+)
IgM Anti-HBC (-)
Anti-HBS (-)
IgG Anti-HBC (+) |
|
Definition
|
|
Term
| Hepatitis transmitted Fecal-oral enteral |
|
Definition
|
|
Term
| Hepatitis transmitted Parenterally |
|
Definition
|
|
Term
|
Definition
- currently infected
- susceptable
|
|
|
Term
|
Definition
- Antibodies immune/resolved infection
- Susceptable
|
|
|
Term
|
Definition
- Self made Antibodies
- Susceptable
|
|
|
Term
|
Definition
- HBsAg (+) >6M
- HBV DNA >20K
- Elevated AST/ALT
- Biopsy showing necroimflammation
|
|
|
Term
| When should treatment for Hep B start? (3) |
|
Definition
- HBsAg (+) >6M
- HBV DNA >20K
- ALT >60 X 3-6M
|
|
|
Term
| When can treatment of Hep B end? |
|
Definition
- Seroconversion + undetectable viral DNA
- At least 6M after anti-HBe
|
|
|
Term
|
Definition
- Peg-IF A2
- Entecavir
- Tenofovir
|
|
|
Term
| Which drug is CI in patients with a CRcl <50? |
|
Definition
| Ribavirin is CI in Renal insufficiency |
|
|
Term
| Which drugs are NOT renally dose adjusted? |
|
Definition
|
Prevent the need to dose adjust |
|
|
Term
| CI as Hep B monotherapy in PT with HIV |
|
Definition
|
|
Term
|
Definition
|
|
Term
| How do we confirm the diagnosis of hep C infection |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Which drug is teratogenic? |
|
Definition
Ribavirin
use two forms of backup
|
|
|
